UK watchdog says it may accept remedies in $35 bln Synopsys-Ansys deal (updated)
08/01/2025 11:41
(Adds details on probe in paragraph 4, Synopsys response in
paragraph 5)
Jan 8 (Reuters) - The UK's competition regulator said on
Wednesday it might accept remedies offered by chip design
software maker Synopsys SNPS.O and Ansys ANSS.O to address
the concerns raised over their $35 billion deal.
Synopsys announced its cash-and-stock deal for Ansys, whose
software is used to make products ranging from airplanes to
tennis rackets, in January last year.
The Competition and Markets Authority said the undertakings
offered on Dec. 31 included the divestment of Ansys' power
consumption analysis product for digital chips and Synopsys'
sale of its global optics and photonics software business.
The CMA said it has until March 5 to decide whether to
accept the undertakings, with the possibility to extend the
deadline to May 6.
A Synopsys spokesperson said the companies are pleased with
the regulator's decision, adding that the duo will maintain its
"constructive and collaborative engagement" with the CMA.
(Reporting by Aby Jose Koilparambil and Prerna Bedi in
Bengaluru; Editing by Shilpi Majumdar)
((abyjose.koilparambil@thomsonreuters.com))